MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

Welcome to this Pulsz referral code guide that’ll delve deeper into everything you need to know about this sweepstakes casino’s referral bonus. We’ll be taking a closer look at how easily you can ...

Also: Centuri buys an electric utility services company in Canada.